Immunome Inc. (IMNM) earnings date

Nasdaq · Mid cap · EDGAR filings

Email me when this date changes · free account, one click to stop

How this company behaves

Announces its report date Not enough announcements on file yet to say
Reports after the quarter ends 42 days, typically, give or take 15 (last 8 releases)

Last 8 releases

PeriodReleasedTimingDays after period endFiling
Q3 FY2026Mon, Nov 9, 2026after close 40 8-K
Q2 FY2026Tue, Aug 11, 2026after close 42 8-K
Q1 FY2026Tue, May 12, 2026after close 42 8-K
Q4 FY2025Tue, Mar 3, 2026after close 62 8-K
Q3 FY2025Thu, Nov 6, 2025after close 37 8-K
Q2 FY2025Wed, Aug 6, 2025after close 37 8-K
Q1 FY2025Mon, May 12, 2025after close 42 8-K
Q4 FY2024Wed, Mar 19, 2025after close 78 8-K

What they guided beta

Q3 FY2026 "Investigational New Drug (IND) clearance received for IM-1340, a potential first-in-class solid tumor antibody-drug conjugate (ADC), with Phase 1 trial initiation expected by year-end 2026 BOTHELL, Wash. – Immunome, Inc. (Nasdaq: IMNM), a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class cancer therapies, today announced financial results for the quarter ended September 30, 2026, and provided a business update." exhibit
Q3 FY2026 "IM-1021 : The Phase 1 clinical trial of IM-1021 is ongoing, and Immunome expects to present an updated dataset at the 2026 American Society of Hematology (ASH) Annual Meeting on December 14, 2026." exhibit
Q3 FY2026 "Preclinical ADC Pipeline : Immunome expects to submit an IND for IM-1335 in late 2026." exhibit
Q3 FY2026 "Immunome expects its current cash position to fund operations into 2028." exhibit
Q2 FY2026 "Immunome expects to present initial lymphoma data for IM-1021 in 2026." exhibit
Q2 FY2026 "Preclinical ADC Pipeline : Immunome expects to submit Investigational New Drug applications (INDs) for IM-1340 and IM-1335 in mid- and late 2026, respectively." exhibit
Q2 FY2026 "Immunome expects its current cash position to fund operations into 2028." exhibit

Get this as JSON

curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/next/IMNM
# how far back the record goes for this company
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/coverage/IMNM

Put this date on your page

A badge that stays current. It links back to this page and needs no key. Embed it unmodified, with its link to this page intact: the badge is too small to carry the notice below, so the page it links to does.

Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.

IMNM earnings date badge

HTML

<a href="https://veritasdata.dev/company/IMNM/"><img src="https://veritasdata.dev/embed/IMNM.svg" alt="IMNM earnings date" width="240" height="56"></a>

Markdown

[![IMNM earnings date](https://veritasdata.dev/embed/IMNM.svg)](https://veritasdata.dev/company/IMNM/)

Script

<script async src="https://veritasdata.dev/embed/IMNM.js"></script>

Get a free key: 100 calls, every company

Sign in with GitHub or Google. The key works on every endpoint and in the MCP server.

curl -H "X-API-Key: vt_live_..." "https://api.veritasdata.dev/v1/next/IMNM"

Dates come only from SEC EDGAR and company announcements. Nothing here is investment advice.